Breast cancer Posts - Page 6 of 80 on Medivizor

Evaluating the association of physical activity and sedentary behavior with fatigue, pain, and depressive symptoms among breast cancer survivors.

Posted by Medivizor on Oct 3, 2021 in Breast cancer | 0 comments

In a nutshell This study examined the association of physical activity (PA) and sedentary time (ST) with pain, fatigue, and depressive symptoms over time among survivors of breast cancer (BC). The data showed that lower ST and higher PA is associated with lower depressive symptoms in long-term survivors of BC. Some background BC is one of the most...

Evaluating the occurrence and predictors of peripheral nerve disease after breast cancer treatment.

Posted by Medivizor on Oct 3, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the occurrence and clinical predictors of peripheral neuropathy (PN; nerve damage) in long-term survivors of breast cancer (BC). The data showed that PN is an important long-term consequence of taxane-based chemotherapy in survivors of BC. Some background BC is one of the most common forms of cancer in women....

Which combination of treatments is better for HER2 positive advanced breast cancer?

Posted by Medivizor on Sep 17, 2021 in Breast cancer | 0 comments

In a nutshell This study compared two treatment regimes for HER2 positive breast cancer; pyrotinib (Irene) plus vinorelbine (Navelbine), or lapatinib (Tykerb) plus capecitabine (Xeloda). It found that pyrotinib plus vinorelbine (PV) improved survival without cancer progressing compared to lapatinib plus capecitabine (LC). Some background...

Comparing platinum-based chemotherapy and immunotherapy for the treatment of patients with early-stage triple negative breast cancer.

Posted by Medivizor on Sep 12, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness and safety outcomes of platinum-based chemotherapy and immune checkpoint inhibitors (ICIs) for the treatment of patients with early-stage triple-negative breast cancer (TNBC). The data showed that ICI plus chemotherapy was associated with good outcomes with reduced side effects compared with...

Tucatinib plus trastuzumab and capecitabine preserves health-related quality of life in patients with metastatic HER2-positive breast cancer.

Posted by Medivizor on Sep 5, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the impact of tucatinib (Tukysa) in combination with trastuzumab (Herceptin) and capecitabine (Xeloda) on health-related quality of life (HR-QoL) in patients with metastatic human epidermal growth factor (HER2)-positive breast cancer (BC). The data showed that this combination preserved HR-QoL in these patients. Some...

Evaluating the benefits of denosumab on bone health in women with early-stage breast cancer.

Posted by Medivizor on Sep 5, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the benefits of denosumab (Xgeva) on the bone health of women with early-stage breast cancer (BC). The data showed that denosumab improved bone-related outcomes in women with high-risk early-stage BC Some background BC is one of the most common forms of cancer in women. Early-stage BC is used to describe BC that is...

Evaluating eribulin versus other treatment options in women with advanced breast cancer.

Posted by Medivizor on Aug 29, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the safety and effectiveness between eribulin (Halaven) and non-eribulin-based chemotherapy regimens in patients with advanced breast cancer (BC). The data showed that eribulin significantly improved survival outcomes with manageable side effects in these patients. Some background Advanced BC has spread...

Evaluating the effects of adding chemotherapy to trastuzumab treatment on mental functioning in older patients with HER2-positive breast cancer.

Posted by Medivizor on Aug 29, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated the effects of adding chemotherapy to trastuzumab (Herceptin) treatment on cognitive (thinking and reasoning) functioning in older patients with HER2-positive (HER2+) breast cancer (BC). The data showed that the addition of chemotherapy did not impact cognitive functioning in these women. Some...

Does lumpectomy followed by radiation improve survival outcomes in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes?

Posted by Medivizor on Aug 22, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the survival outcomes after lumpectomy followed by radiation versus mastectomy alone in patients with early-stage HER2-positive (HER2+) breast cancer (BC) and triple-negative breast cancer (TNBC) with low or high tumor-infiltrating lymphocytes (TILs). The data showed that lumpectomy followed by radiation improves...

Evaluating the frequency and outcomes of contralateral axillary metastasis in patients with inflammatory breast cancer.

Posted by Medivizor on Aug 15, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated the frequency and outcomes of contralateral axillary metastasis (CAM) in patients with inflammatory breast cancer (IBC). The data showed that CAM was common at diagnosis in patients with IBC and was best identified by ultrasound and positron emission tomography (PET). Some background IBC is a rare and aggressive...

Searching for patients with unresponsive breast cancer to trial an experimental treatment.

Posted by Medivizor on Aug 15, 2021 in Breast cancer | 0 comments

In a nutshell This trial aims to assess the safety and effectiveness of an experimental drug, CYT-0851 in the treatment of B-cell and solid tumors, including breast cancer, that have come back or are no longer responsive to treatments. The main outcomes to be measured are the side effects and the overall response to the treatment....

Comparing the recurrence rates of breast cancer after immediate or delayed breast reconstruction.

Posted by Medivizor on Aug 15, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the rates of local, regional, and distant recurrence between patients who received immediate or delayed autologous deep inferior epigastric perforators (DIEP) flap breast reconstruction (BR). The data showed that there is an increased risk for breast cancer (BC) recurrence in women who received a delayed BR...

Breast cancer Posts on Medivizor

Evaluating the association of physical activity and sedentary behavior with fatigue, pain, and depressive symptoms among breast cancer survivors.

Evaluating the occurrence and predictors of peripheral nerve disease after breast cancer treatment.

Which combination of treatments is better for HER2 positive advanced breast cancer?

Comparing platinum-based chemotherapy and immunotherapy for the treatment of patients with early-stage triple negative breast cancer.

Tucatinib plus trastuzumab and capecitabine preserves health-related quality of life in patients with metastatic HER2-positive breast cancer.

Evaluating the benefits of denosumab on bone health in women with early-stage breast cancer.

Evaluating eribulin versus other treatment options in women with advanced breast cancer.

Evaluating the effects of adding chemotherapy to trastuzumab treatment on mental functioning in older patients with HER2-positive breast cancer.

Does lumpectomy followed by radiation improve survival outcomes in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes?

Evaluating the frequency and outcomes of contralateral axillary metastasis in patients with inflammatory breast cancer.

Searching for patients with unresponsive breast cancer to trial an experimental treatment.

Comparing the recurrence rates of breast cancer after immediate or delayed breast reconstruction.

Categories

Recent Posts

Archives

Breast cancer Posts on Medivizor

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email